Lung cancer is a very common malignant tumor, and it develops rapidly and is highly metastatic. Most patients have already metastasized by the time lung cancer is discovered, which makes it tricky to treat, and biologic therapy can solve this trouble.
In order to treat such lung cancer, the treatment methods adopted in the past are easy to overdo, like surgery for patients with distant metastasis of lung cancer. At this time, their organism is generally in poor condition, and if surgery is performed, it may lead to the spread of cancer cells, and the damage to the organism from surgery and its complications may end the patient’s life prematurely. In addition, chemotherapy and radiotherapy can seriously affect resistance and damage vital organs. Therefore, “the pain caused by surgery or intense treatment such as chemotherapy or radiotherapy may be heavier than the cancer itself” and may even hasten death. However, when a patient has advanced symptoms, it is not pronounced that the patient has lost the possibility of life extension, but rather, a reasonable treatment plan should be formulated in response to different symptoms.
Lung cancer is currently the most common malignant tumor in the world and is the leading cause of cancer death in human beings.
Clinically, surgery is the first and most effective treatment for early symptoms of lung cancer, and the 5-year survival rate of surgery reaches 40%-50%, among which the clinical benefit rate of early stage lung cancer patients can reach 70%-85%. Non-surgical treatment, such as radiotherapy, has a 5-year survival rate of less than 3% regardless of the method applied, and 90% of patients die within one year. Moreover, the choice of radiotherapy and chemotherapy should be based on tumor remission, symptom relief, and treatment-related toxicity.
Nowadays, there is a “spring” in the world of cancer – lung cancer biotherapy has been born. API specific biological immunotherapy is a new technology with high target, relapse prevention, low side effects, immunity enhancement, maintenance of body physiological balance, strong killing of cancer cells and prevention of cancer recurrence and metastasis. It rescues patients from the pain of endless radiotherapy and chemotherapy and gives them hope for life.
Some researchers chose 150 patients for the experiment, and they randomly divided these people into two groups for the clinical trial study: among the patients who used biologic treatment for lung cancer, the recurrence-free rate was 72% after 3 years. The recurrence rate was 33% after 3 years for those who did not use biologic cell therapy, 67% for those who used biologic cell therapy after 5 years, and 22% for those who did not use biologic cell therapy. The study confirmed that biologic therapy can prolong the survival time of lung cancer patients and inhibit the recurrence of lung cancer. Therefore, biological treatment for lung cancer is the most appropriate and effective treatment method that is non-invasive to the body at present.
Biological immunotherapy for lung cancer, also known as autoimmune cell therapy, is the fourth new technology to overcome the disadvantages of surgery, radiotherapy and chemotherapy, such as incomplete, metastasis-prone, recurrence-prone and large side effects, to effectively improve patients’ quality of life and prolong their survival time.
Comprehensive Treatment
Tumor fractionated comprehensive treatment is to apply the existing treatments in a planned and rational way according to the patient’s body condition, pathological type, invasion scope and development trend of tumor, in order to maximize the cure rate and improve the survival quality. It is a new type of treatment program for tumors at the present stage, and is the basic principle of most tumor treatments in the 21st century.
Biological therapy for lung cancer can maximize the mobilization of human immune function, minimize the number of residual tumor cells in the body, significantly improve the quality of life of patients, and effectively increase the survival period of tumor patients, which is a more advanced and effective treatment means. It can be considered as a gospel for lung cancer patients.
API-specific bioimmunotherapy can not only rapidly improve the symptoms of lung cancer, such as: lung pain, fever, abdominal distension and ascites, but also effectively control the growth of tumor without toxic side effects and invasiveness. Combined with radiotherapy, it can also reduce the toxic side effects of radiotherapy and enhance the therapeutic effect of radiotherapy. For lung cancer patients who cannot be treated with radiotherapy in the middle and late stages, they can also directly adopt lung cancer biotherapy alone, which can effectively reduce patients’ pain, remove scattered tumor cells in the body and prevent recurrence and metastasis of many kinds of tumors after surgery; lung cancer patients in recovery stage can adopt lung cancer biotherapy for consolidation treatment, which can control lung cancer cell metastasis and recurrence, enhance immunity, and improve patients’ quality of life and improve their Survival.
Biological therapy is “own cells to kill cancer cells”, which is a combination of two types of cells, dendritic cells (DC) and cytokine-induced killer cells (CIK), to treat tumors. Biological therapy can not only stimulate and enhance the specific anti-tumor immune response of tumor patients and effectively remove residual lesions in the body, but also induce immune memory in the patient’s body to obtain long-term anti-tumor effect, thus preventing recurrence of tumor due to residual lesions after conventional treatment, which is a new, specific and effective treatment. It can effectively avoid the adverse effects of chemotherapy, significantly improve the quality of life of patients with advanced tumors, and truly allow patients to “live with tumors”.
The latest technology of lung cancer treatment, API specific biological cell immunotherapy, has been clinically proven in the United States to systematically kill tumor cells and effectively solve their metastasis and spread, overcoming the drawbacks of surgery, radiotherapy and chemotherapy, which are incomplete, prone to metastasis and have large side effects. It is the fourth most promising new technology for the complete elimination of tumor cells. Dr. Yamazaki, a famous oncologist, has made a comparison between bioimmunotherapy and traditional treatment. The study showed that the 3-year survival rate of American tumor patients treated with bioimmunotherapy was 72%, compared to 33% for those who did not use it, and the 5-year survival rate was 67%, compared to 22% for those who did not use it. The results were promising. Therefore, bioimmunotherapy can effectively prolong the survival of patients and is the best choice for tumor patients.
Nowadays, biologic therapy, the latest technology for lung cancer treatment, has been recognized as the fourth tumor treatment method after surgery, chemotherapy and radiotherapy, and is one of the most active and promising treatment methods in the comprehensive tumor treatment mode in the 21st century, with its advantages of safety, effectiveness, non-toxic side effects, significantly improving patients’ quality of life and increasing survival expectation.
Advantages and efficacy
1.Simple method-no surgery, no chemotherapy, no radiotherapy, the whole process is just like an IV.
2.Strongly targeted-The treatment is based on different kinds, types, stages and constitutions of cancer, and the corresponding targeted anti-cancer herbal medicines are selected for treatment, therefore, the cure rate is high.
3. No toxic side effects – This series of drugs are pure natural Chinese herbal medicines, which are refined by modern technology and have little stimulation to the gastrointestinal tract and will not damage the hematopoietic function of bone marrow, so there are no toxic side effects.
4, has been included in the medical insurance – biological treatment costs have been included in the scope of medical insurance, for the majority of patients can reduce a lot of pressure on the cost of treatment.
5.Fast effect – Generally, patients can have significant effect after one course of treatment, and they can feel relief of their symptoms and the tumor becomes softer and smaller. For most cancer patients, the tumor disappears after three courses of treatment and achieves the purpose of recovery, while some patients can see the effect in about 10 days and a few patients can see the effect within a week.
6.Cure the root cause – Fuzheng anti-cancer detoxification therapy can not only kill cancer cells and eliminate tumor, but also protect normal cells, increase the number of white blood cells, improve the immunity of the body, eliminate the toxins of cancer tumor, cure cancer fundamentally, and no recurrence after cure.
7.Kill residual cancer cells: Biological immunotherapy can effectively remove residual cancer cells and microscopic lesions after surgery and radiotherapy, which can better prevent recurrence and metastasis of lung cancer.
8.Improve the sensitivity of radiotherapy and chemotherapy: Bioimmunotherapy can enhance the sensitivity of radiotherapy and chemotherapy and enhance the treatment effect.
9.Restoring physical strength: Biological immunotherapy treatment can make patients’ mental state and physical strength recover significantly, which can greatly improve the ability of lung cancer patients to resist cancer cell erosion, thus allowing patients to obtain longer survival period and better quality of life.
10.Relieving late symptoms: For patients with advanced lung cancer who have lost the chance of surgery or whose cancer cells have recurred or metastasized, biological immunotherapy can relieve their clinical symptoms, reduce their pain and improve their survival treatment.
11.Prolonging survival: For patients who are ineffective in radiotherapy or resistant to chemotherapy drugs, biological immunotherapy can be used to prolong survival.
Problems of conventional therapy
Biological immunotherapy advantages
Surgery
1. Causes extensive immune damage in the body of tumor patients 1. Restores immune damage caused by surgery 2. Causes injury to the body and even organs 2. Rapidly removes residual tumor cells after surgery
3. Causing dysfunction of corresponding organ system of surgery
3.Eliminate the recurrence and metastasis of tumor